Fideuram Intesa Sanpaolo Private Banking S.P.A. reduced its position in shares of Corteva, Inc. (NYSE:CTVA – Free Report) by 7.3% in the first quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 132,291 shares of the company’s stock after selling 10,347 shares during the quarter. Fideuram Intesa Sanpaolo Private Banking S.P.A.’s holdings in Corteva were worth $11,074,000 as of its most recent filing with the Securities & Exchange Commission.
Other institutional investors have also added to or reduced their stakes in the company. Vanguard Group Inc. grew its stake in shares of Corteva by 0.4% in the fourth quarter. Vanguard Group Inc. now owns 80,536,951 shares of the company’s stock worth $5,398,392,000 after purchasing an additional 317,538 shares during the last quarter. State Street Corp raised its holdings in Corteva by 3.7% in the fourth quarter. State Street Corp now owns 36,570,876 shares of the company’s stock worth $2,451,346,000 after purchasing an additional 1,290,071 shares in the last quarter. Franklin Resources Inc. lifted its position in Corteva by 4.3% during the 4th quarter. Franklin Resources Inc. now owns 19,537,500 shares of the company’s stock valued at $1,309,599,000 after acquiring an additional 805,873 shares during the period. Harris Associates L P lifted its holdings in shares of Corteva by 168.1% during the fourth quarter. Harris Associates L P now owns 17,026,221 shares of the company’s stock valued at $1,141,268,000 after purchasing an additional 10,675,052 shares during the last quarter. Finally, Northern Trust Corp raised its stake in Corteva by 5.0% during the fourth quarter. Northern Trust Corp now owns 11,731,834 shares of the company’s stock valued at $786,385,000 after buying an additional 562,550 shares during the last quarter. Hedge funds and other institutional investors own 81.54% of the company’s stock.
Analysts Set New Price Targets
Several brokerages have recently issued reports on CTVA. CICC Research upped their target price on shares of Corteva from $80.00 to $93.00 and gave the stock an “outperform” rating in a research note on Wednesday, May 13th. The Goldman Sachs Group raised their target price on Corteva from $88.00 to $96.00 and gave the stock a “buy” rating in a research report on Tuesday, April 14th. Oppenheimer lifted their price target on shares of Corteva from $86.00 to $89.00 and gave the stock an “outperform” rating in a research note on Wednesday, April 22nd. Jefferies Financial Group boosted their price objective on Corteva from $95.00 to $97.00 in a research note on Thursday, May 7th. Finally, Berenberg Bank upped their price target on shares of Corteva from $68.00 to $78.00 and gave the stock a “hold” rating in a research report on Thursday, March 26th. Fourteen research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $88.90.
Corteva Stock Performance
Shares of NYSE CTVA opened at $85.63 on Friday. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.03 and a current ratio of 1.47. The company has a market cap of $57.27 billion, a P/E ratio of 50.37, a P/E/G ratio of 2.56 and a beta of 0.56. Corteva, Inc. has a 52-week low of $60.53 and a 52-week high of $85.95. The firm’s fifty day moving average is $79.67 and its two-hundred day moving average is $76.80.
Corteva (NYSE:CTVA – Get Free Report) last released its quarterly earnings results on Tuesday, May 5th. The company reported $1.50 earnings per share for the quarter, beating the consensus estimate of $1.18 by $0.32. The business had revenue of $4.91 billion during the quarter, compared to analysts’ expectations of $4.64 billion. Corteva had a return on equity of 9.95% and a net margin of 6.50%.The firm’s revenue for the quarter was up 11.0% compared to the same quarter last year. During the same quarter last year, the business posted $1.13 EPS. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. As a group, analysts anticipate that Corteva, Inc. will post 3.72 EPS for the current fiscal year.
Corteva Announces Dividend
The firm also recently announced a quarterly dividend, which was paid on Monday, June 15th. Stockholders of record on Monday, June 1st were given a dividend of $0.18 per share. This represents a $0.72 annualized dividend and a dividend yield of 0.8%. The ex-dividend date was Monday, June 1st. Corteva’s dividend payout ratio is currently 42.35%.
Corteva Profile
Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.
Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.
Recommended Stories
- Five stocks we like better than Corteva
- Shorting the Grid: Bloom Energy’s $25B AI Power Play
- SanDisk’s Volatility May Be Telling Bulls What They Want to Hear
- Meta’s AI Compute Push Could Turn Its Massive CapEx Bill Into a Competitive Weapon
- 3 Dividend ETFs Built for Stability in a Volatile Market
Want to see what other hedge funds are holding CTVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Corteva, Inc. (NYSE:CTVA – Free Report).
Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.
